Yuriy A. Abramov, Global R&D, Pharmaceutical Sciences, Pfizer, Inc., Groton, CT, USA

Jacob Albrecht, Product Development, Bristol‐Myers Squibb, New Brunswick, NJ, USA

Ayman Allian, Synthetic Technologies and Engineering, Amgen Inc., Thousand Oaks, CA, USA

David J. am Ende, Nalas Engineering Services, Inc., Centerbrook, CT, USA

Mary T. am Ende, Lyndra Therapeutics, Inc., Watertown, MA, USA

Firoz D. Antia, Antisense Oligonucleotide Process Development and Manufacturing, Biogen Inc., Cambridge, MA USA

Rahul Bhambure, Chemical Engineering and Process Development Division, CSIR – National Chemical Laboratory, Pune, MH, India

Vivek Bhatnagar, Biologics R&D, Teva Pharmaceuticals, Inc., West Chester, PA, USA

Thomas Borchardt, Drug Product Development, AbbVie Inc., North Chicago, IL, USA

Shailendra Bordawekar, Process Research and Development, AbbVie Inc., North Chicago, IL, USA

Timothy Braden, Eli Lilly and Company, Indianapolis, IN, USA

Alan Braem, Product Development, Bristol‐Myers Squibb, New Brunswick, NJ, USA

Shawn Brueggemeier, Product Development, Bristol‐Myers Squibb, New Brunswick, NJ, USA

Justin L. Burt, Eli Lilly and Company, Indianapolis, IN, USA

Lei Cao, Operations Science and Technology, AbbVie Inc., North Chicago, IL, USA

Doug Carmichael, Intelligen, Inc., Scotch Plains, NJ, USA

Matthew Casey, Biogen Inc., Durham, NC, USA

Benjamin Caudle, Texas Tech University, Lubbock, TX, USA

Elie Chaaya, Process Research and Development, AbbVie Inc., North Chicago, IL, USA

Shujauddin M. Changi, Eli Lilly and Company, Indianapolis, IN, USA

Chau‐Chyun Chen, Texas Tech University, Lubbock, TX, USA

Jie Chen, Solid State Chemistry, AbbVie Inc., North Chicago, IL, USA

Shuang Chen, Solid State Chemistry, AbbVie Inc., North Chicago, IL, USA

Yinshan Chen, Solid State Chemistry, AbbVie Inc., North Chicago, IL, USA

Paul C. Collins, Eli Lilly and Company, Indianapolis, IN, USA

Eric M. Cordi, Chemical R&D, Pfizer, Inc., Groton, CT, USA

Andrew Cosbie, Drug Substance Technologies and Engineering, Amgen Inc., Thousand Oaks, CA, USA

Ann M. Czyzewski, Process Research and Development, AbbVie Inc., North Chicago, IL, USA

Gerald Danzer, Drug Product Development, AbbVie Inc., North Chicago, IL, USA

Richard M. Davis, Global Environmental, Health and Safety, Pfizer, Inc., Groton, CT, USA

Philip Dell'Orco, Chemical Development, GlaxoSmithKline, King of Prussia, PA, USA

Lotfi Derdour, Chemical Development, GlaxoSmithKline, King of Prussia, PA, USA

Wim Dermaut, Chemical Process Development, Materials Technology Center, Agfa‐Gevaert NV, Mortsel, Belgium

Nadine Ding, Abbott Vascular, Santa Clara, CA, USA

Moiz Diwan, Process Research and Development, AbbVie Inc., North Chicago, IL, USA

Simon Dufal, Process Systems Enterprise Ltd., London, UK

Elizabeth S. Fisher, Merck & Co., Inc., Rahway, NJ, USA

John Gaertner, Process Research and Development, AbbVie Inc., North Chicago, IL, USA

Jennifer McClary Groh, Eli Lilly and Company, Indianapolis, IN, USA

Daniel M. Hallow, Noramco, Athens, GA, USA

Jason Hamm, Product Development, Bristol-Myers Squibb, New Brunswick, NJ, USA

Joe Hannon, Scale‐up Systems Limited, Dublin, Ireland

Raimundo Ho, Solid State Chemistry, AbbVie Inc., North Chicago, IL, USA

Seth Huggins, Drug Substance Technologies and Engineering, Amgen Inc., Thousand Oaks, CA, USA

Martin D. Johnson, Eli Lilly and Company, Indianapolis, IN, USA

G. Scott Jones, Bristol‐Myers Squibb, New Brunswick, NJ, USA

Matthew Jorgensen, Nalas Engineering Services, Inc., Centerbrook, CT, USA

Manish S. Kelkar, Process Research and Development, AbbVie Inc., North Chicago, IL, USA

Stephen B. Kessler, Impact Technology Development, Lincoln, MA, USA

Avinash R. Khopkar, Reliance Industries Limited, Mumbai, MH, India

Evelina B. Kim, Process Research and Development, AbbVie Inc., North Chicago, IL, USA

Toni E. Kirkes, Texas Tech University, Lubbock, TX, USA

Andreas Klamt, COSMO logic GmbH & Co. KG, Leverkusen, Germany and Institute of Physical and Theoretical Chemistry, University of Regensburg, Regensburg, Germany

Michael E. Kopach, Eli Lilly and Company, Indianapolis, IN, USA

Brian Kotecki, Process Research and Development, AbbVie Inc., North Chicago, IL, USA

Alexandros Koulouris, Alexander Technological Education Institute of Thessaloniki, Thessaloniki, Greece

Joseph F. Krzyzaniak, Global R&D, Pharmaceutical Sciences, Pfizer, Inc., Groton, CT, USA

Joseph L. Kukura, Merck Research Laboratories, Merck & Co., Inc., Rahway, NJ, USA

Sourav Kundu, Biologics R&D, Teva Pharmaceuticals, Inc., West Chester, PA, USA

Thomas Lafitte, Process Systems Enterprise Ltd., London, UK

Pericles Lagonikos, Merck & Co., Inc., Singapore, Singapore

Thomas L. LaPorte, Product Development, Bristol‐Myers Squibb, New Brunswick, NJ, USA

Carl LeBlond, Department of Chemistry, University of Pennsylvania, Indiana, PA, USA

Huayu Li, Material and Analytical Sciences, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA

Christoph Loschen, COSMO logic GmbH & Co. KG, Leverkusen, Germany

Michael Lovette, Drug Substance Process Development, Amgen Inc., Thousand Oaks, CA, USA

Carla V. Luciani, Eli Lilly and Company, Indianapolis, IN, USA

Brendan Mack, Product Development, Bristol‐Myers Squibb, New Brunswick, NJ, USA

James C. Marek, Process Research and Development, AbbVie Inc., North Chicago, IL, USA

Brian L. Marquez, Nalas Engineering Services, Inc., Centerbrook, CT, USA

Alessandra Mattei, Solid State Chemistry, AbbVie Inc., North Chicago, IL, USA

Scott A. May, Eli Lilly and Company, Indianapolis, IN, USA

Francis X. McConville, Impact Technology Development, Lincoln, MA, USA

Robert McKeown, Chemical Development, GlaxoSmithKline, King of Prussia, PA, USA

Jeremy Miles Merritt, Eli Lilly and Company, Indianapolis, IN, USA

Melanie Miller, Product Development, Bristol-Myers Squibb, New Brunswick, NJ, USA

Laurie Mlinar, Process Research and Development, AbbVie Inc., North Chicago, IL, USA

Saravanababu Murugesan, Product Development, Bristol‐Myers Squibb, New Brunswick, NJ, USA

Subramanya Nayak, Process Research and Development, AbbVie Inc., North Chicago, IL, USA

Nandkishor K. Nere, Process Research and Development, AbbVie Inc., North Chicago, IL, USA

Roger Nosal, Global CMC, Pfizer, Inc., Groton, CT, USA

Jeffrey Nye, Product Development, Bristol‐Myers Squibb, New Brunswick, NJ, USA

Chuck Orella, Merck & Co., Inc., Rahway, NJ, USA

Ajinkya Pandit, Chemical Engineering and Process Development Division, CSIR – National Chemical Laboratory, Pune, MH, India

Constantinos C. Pantelides, Process Systems Enterprise Ltd., London, UK

Vasileios Papaioannou, Process Systems Enterprise Ltd., London, UK

Naveen Pathak, Process Development and Technical Services, Shire plc, Cambridge, MA, USA

Klimentina Pencheva, Global R&D, Pharmaceutical Sciences, Pfizer, Inc., Sandwich, UK

Demetri Petrides, Intelligen, Inc., Scotch Plains, NJ, USA

Laura Poloni, Department of Chemical Engineering and Applied Chemistry, University of Toronto, Ontario, Canada

Antonio Ramirez, Product Development, Bristol‐Myers Squibb, New Brunswick, NJ, USA

Tom Ramsey, Janssen, Raritan, NJ, USA

Vivek V. Ranade, School of Chemistry and Chemical Engineering, Queen's University of Belfast, Belfast, UK

Brandon J. Reizman, Eli Lilly and Company, Indianapolis, IN, USA

Steven Richter, Process Research and Development, AbbVie Inc., North Chicago, IL, USA

Megan Roth, Chemical Engineering R&D, Merck & Co., Inc., Rahway, NJ, USA

Richard Schild, TG Therapeutics, Inc. New York City, NY, USA

Kevin D. Seibert, Eli Lilly and Company, Indianapolis, IN, USA

Vaidyaraman Shankarraman, Eli Lilly and Company, Indianapolis, IN, USA

Praveen K. Sharma, Chemical Development, Tetraphase Pharmaceuticals, Inc., Watertown, MA, USA

Ahmad Y. Sheikh, Solid State Chemistry, AbbVie Inc., North Chicago, IL, USA

Yujin Shin, Solid State Chemistry, AbbVie Inc., North Chicago, IL, USA

Charles Siletti, Intelligen, Inc., Scotch Plains, NJ, USA

Utpal K. Singh, Eli Lilly and Company, Indianapolis, IN, USA

Kushal Sinha, Process Research and Development, AbbVie Inc., North Chicago, IL, USA

Kamalesh K. Sirkar, New Jersey Institute of Technology, Newark, NJ, USA

Dimitri Skliar, Product Development, Bristol‐Myers Squibb, New Brunswick, NJ, USA

Sushil Srivastava, Bristol‐Myers Squibb, New Brunswick, NJ, USA

Gregory S. Steeno, Worldwide Research and Development, Pfizer, Inc., Groton, CT, USA

Andrew Stewart, Allergan, Irvine, CA, USA

Yongkui Sun, Ionova Life Science Co., Ltd., Shenzhen, China

Flavien Susanne, Product and Process Engineering, GSK Medicines Research Centre, GlaxoSmithKline, Stevenage, UK

Jason Sweeney, Product Development, Bristol‐Myers Squibb, New Brunswick, NJ, USA

Jose E. Tabora, Product Development, Bristol‐Myers Squibb, New Brunswick, NJ, USA

Michael P. Thien, Merck Manufacturing Division, Merck & Co., Inc., Whitehouse Station, NJ, USA

Jean Tom, Product Development, Bristol‐Myers Squibb, New Brunswick, NJ, USA

Srinivas Tummala, Bristol‐Myers Squibb, New Brunswick, NJ, USA

Gillian Turner, Product Development and Supply, GlaxoSmithKline, Stevenage, UK

Cenk Undey, Process Development, Amgen Inc., Thousand Oaks, CA, USA

Dimitris Vardalis, Intelligen, Inc., Scotch Plains, NJ, USA

Anuj A. Verma, Process Research and Development, AbbVie Inc., North Chicago, IL, USA

Tom Vickery, Chemical Engineering R&D, Merck & Co., Inc., Rahway, NJ, USA

Chenchi Wang, Manufacturing Science and Technology, Bristol‐Myers Squibb, New Brunswick, NJ, USA

Timothy J. Watson, Global CMC, Pfizer, Inc., Groton, CT, USA

James Wertman, Technical Operations, Theravance Biopharma, South San Francisco, CA, USA

Karin Wichmann, COSMO logic GmbH & Co. KG, Leverkusen, Germany

R. Thomas Williamson, Department of Chemistry & Biochemistry, University of North Carolina Wilmington, Wilmington, NC, USA

Xinmin (Sam) Xu, Abbott Vascular, Santa Clara, CA, USA

Cheng‐Hsiu Yu, Texas Tech University, Lubbock, TX, USA

Dimitrios Zarkadas, Merck & Co., Inc., Rahway, NJ, USA

Mark Zell, Takeda Oncology, Cambridge, MA, USA